Everardo Saad
10PUBLICATIONS
38CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Oct 25, 2023
Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimen.Mickaël De Backer, Manju Sengar, Vikram Mathews
|Sep 28, 2023
Trial Design for Cancer Immunotherapy: A Methodological Toolkit.Everardo D Saad, Elisabeth Coart, Vaiva Deltuvaite-Thomas
|Apr 19, 2023
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.Marion T van Mackelenbergh, Sibylle Loibl, Michael Untch
|Mar 28, 2023
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy.Pierre Squifflet, Everardo D Saad, Sibylle Loibl
|Apr 05, 2022
Surrogacy Beyond Prognosis: The Importance of "Trial-Level" Surrogacy.Marc Buyse, Everardo D Saad, Tomasz Burzykowski
|Dec 05, 2021
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology.Richard M Goldberg, Richard Adams, Marc Buyse
Pageof 2
Frequent Collaborators
6 joint publications
Marc Buyse
2 joint publications
Luca Gianni
2 joint publications
Pierfranco Conte
2 joint publications
Michael Untch
2 joint publications
Hervé Bonnefoi
2 joint publications
Martine Piccart
2 joint publications
Tomasz Burzykowski
2 joint publications
Andreas Schneeweiss
2 joint publications
Marion T van Mackelenbergh
2 joint publications
Sibylle Loibl
